Page results
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.
-
Using MRI alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to research from UCLH, UCL and King’s College London.
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
The Elizabeth Garrett Anderson maternity service at UCLH has been rated ‘Good’ following an inspection by the Care Quality Commission (CQC) in June 2023.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
File results
-
FOI/2023/0119 - Post occupancy evaluations following completion of a capital project
-
FOI/2023/0117 - EPRR Team contact information
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0111 - Migraine treatment
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles